SpaceX (SPCX) finally showed public investors the numbers.
Second-quarter revenue came in around $7.8 billion. Wall Street was looking for something closer to the high $6 billions. Adjusted EBITDA landed near $3.5 billion. The stock ripped after the print and closed Tuesday near $125 after spending July looking punch-drunk under the IPO price.
That is the cable-news version. Clean beat. Musk company. Next ticker.
The version that actually matters for holders starts about 48 hours later.
The supply wave everybody keeps soft-pedaling
On Thursday, August 6, the first big post-IPO lockup unlock hits. Reporting around the event puts roughly 911 million shares in play for employees and early holders. That is not a rounding error. It more than doubles the freely tradeable float from the tiny slice that floated at the June debut.
Eligible to sell is not the same as everyone dumping at the open. True. People still need a bid. Taxes exist. Loyalty exists. But markets do not need every unlocked share to print for the overhang to matter. They need enough sellers to meet a crowd that already spent July betting against the stock.
Short interest had already climbed into the hundreds of millions of shares, with the bear case worth tens of billions of dollars and, at points, larger than the short book against Tesla (TSLA). The bet was blunt: unlock volume wins unless the fundamental story is so strong nobody cares about supply.
Tuesday's earnings bounce was the bulls' first real counterpunch. Thursday is the shorts' scheduled artillery window.
What the quarter actually proved
Give the company its due.
Growing revenue nearly double-digit multiples of many industrial names, and printing multi-billion adjusted EBITDA in the first fully public quarter, is not a fake company. Starlink, launch cadence, and the AI-adjacent connectivity pitch all got a cleaner scoreboard. A net loss still showed up on the GAAP line. Nobody serious thought SpaceX was going to look like a mature software printer overnight.
So the fundamental debate is no longer "is this real?" It is "how much of the future did the IPO price already pull forward, and how much patience does the tape have while restricted stock becomes real stock?"
That is a harder argument than cheerleading a revenue beat.
The backyard read
Don't get me wrong. A $7.8 billion quarter is a serious business.
Don't be fooled either. IPO romance dies in unlock calendars. SpaceX went from a scarce private trophy to a public football with a thin float, a loud short base, and a multi-stage unlock schedule that keeps dripping supply for months. August 6 is chapter one, not the whole book.
If long-term allocators step in under the noise, ugly sessions become inventory. If the bid is mostly momentum tourists recycling the same Musk trade, every bounce can get sold into the unlock tape.
One green session after earnings does not settle that fight.
What "winning" looks like from here
A clean unlock week does not require the stock to go vertical. It requires the bid to absorb supply without turning Tuesday's earnings bounce into a trap door. Volume, borrow fees, and whether the stock holds above the pre-print range matter more than any one cable hit about revenue.
If SPCX keeps the bulk of the post-earnings gain while the float expands, longs can argue the fundamental story finally overpowered the calendar. If the stock bleeds on heavy volume into and through Thursday, the market is telling you the overhang is still the boss. Either outcome is information. Pretending the unlock is a nothing-burger is not.
Bottom Line
SpaceX's first public earnings report was strong enough to remind people this is still one of the most important industrial companies on Earth. The stock fight this week is still about float math.
Watch Thursday's unlock behavior more than the victory-lap headlines. If buyers defend this area while hundreds of millions of newly eligible shares hit the market, the earnings bounce had a spine. If the stock coughs up the gain on volume, the market just told you supply still runs the near-term story.
Comments
Log in or sign up to join the conversation.